III - Bibliographie :


A :

L.F. Agnati, K. Fuxe, M. Zoli, I. Ozini, G. Toffano and F. Ferraguti, 1986, A correlation analysis of the regional distribution of central enkephalin and beta-endorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission, Acta Physiol Scand, 128, 2, 201-7

L.F. Agnati, M. Tiengo, F. Ferraguti, G. Biagini, F. Benfenati, C. Benedetti, M. Rigoli and K. Fuxe, 1991, Pain, analgesia, and stress: an integrated view, Clin J Pain, 7, Suppl 1, S23-37

K.J. Anselmino and F. Hoffmann, 1966, The fat-metabolism hormone of the anterior pituitary (lipo-tropin). Its role in fat metabolism under normal and abnormal conditions, Ger Med Mon, 11, 5, 177-80


B :

K.M. Bell and J.R. Traynor, 1998, Dynorphin A(1-8): stability and implications for in vitro opioid activity, Can J Physiol Pharmacol, 76, 3, 325-33

T. Bisogno, S. Maurelli, D. Melck, L. De Petrocellis and V. Di Marzo, 1997, Biosynthesis, uptake, and degradation of anandamide and palmitoyletha-nolamide in leukocytes, J Biol Chem, 272, 6, 3315-23

J. Bockaert and J.P. Pin, 1999, Molecular tinkering of G protein-coupled receptors: an evolutionary success, Embo J, 18, 7, 1723-9

S.K. Böhm, E.F. Grady and N.W. Bunnett, 1997, Regulatory mechanisms that modulate signalling by G -protein-coupled receptors, Biochem J, 322, Pt 1, 1-18

J.M. Botto, 1997, La famille des récepteurs membranaires couplés aux protéines-G. Un modèle d'étude ; les récepteurs des neuropeptides neuroten-sine et neuromédine-N, Nice-Sophia Antipolis.

J. Bradwejn, 1993, Neurobiological investigations into the role of cholecystokinin in panic disorder, J Psychiatry Neurosci, 18, 4, 178-88

M.A. Bunin and R.M. Wightman, 1999, Paracrine neurotransmission in the CNS : involvment of 5-HT, TINS, 22, 9, 377-382

M.C. Burgevin, M.N. Castel, D. Quarteronet, T. Chevet and P.M. Laduron, 1992, Neurotensin increases tyrosine hydroxylase messenger RNA-positive neurons in substantia nigra after retrograde axonal transport, Neuroscience, 49, 3, 627-33


C :

A. Calas, 1998, Les neurones, in Physiologie des neurones, Doin éditeur, Paris D. Tritsh, D. Chesnoy-Marchais and A. Feltz, pp1-29

M.N. Castel, D. Faucher, F. Cuine, P. Dubedat, A. Boireau and P.M. Laduron, 1991, Identification of intact neurotensin in the substantia nigra after its retrograde axonal transport in dopaminergic neurons, J Neurochem, 56, 5, 1816-8

J.P. Changeux, D. Bertrand, P.J. Corringer, S. Dehaene, S. Edelstein, C. Lena, N. Le Novere, L. Marubio, M. Picciotto and M. Zoli, 1998, Brain nicotinic receptors: structure and regulation, role in learning and reinforcement, Brain Res Brain Res Rev, 26, 2-3, 198-216

Y. Combarnous, 1994, Biochimie des communi-cations cellulaires, Lavoisier, Technique et Documen-tation, 67-77

S. Cvejic and L.A. Devi, 1997, Dimerization of the delta opioid receptor: implication for a role in receptor internalization, J Biol Chem, 272, 43, 26959-64


D :

A. Dendorfer, D. Vordermark and P. Dominiak, 1997, Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells, Br J Pharmacol, 120, 1, 121-9

L. Descarries, V. Gisiger and M. Steriade, 1997, Diffuse transmission by acetylcholine in the CNS, Prog Neurobiol, 53, 5, 603-25

L. Descarries, K.C. Watkins, S. Garcia, O. Bosler and G. Doucet, 1996, Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neo-striatum: a quantitative autoradiographic and immuno-cytochemical analysis, J Comp Neurol, 375, 2, 167-86

P. Deterre and D. Tritsh, 1998, Les récepteurs couplés aux G-protéines et la modulation des canaux ionqiques, Doin éditeur, Paris, in Physiologie du neurone, D. Tritsh, D. Chesnoy-Marchais and A. Feltz, pp 323-370

M. Dumont and S. Lemaire, 1998, Characterization of the high affinity [3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site, J Mol Cell Cardiol, 30, 12, 2751-60


E :

A. Elhusseiny, Z. Cohen, A. Olivier, D.B. Stanimirovic and E. Hamel, 1999, Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular lo-calization, J Cereb Blood Flow Metab, 19, 7, 794-802

J. Eng, H.R. Li and R.S. Yalow, 1990, Purification of bovine cholecystokinin-58 and sequencing of its N- terminus, Regul Pept, 30, 1, 15-9

J. Epelbaum, 1995, Neuropeptides et neuro-médiateurs, éditions INSERM, 251-260


F :

M.C. Fournie-Zaluski, C. Durieux, B. Lux, J. Belleney, P. Pham, D. Gerard and B.P. Roques, 1985, Conformational analysis of cholecystokinin fragments CCK4, CCK5, and CCK6 by 1H-NMR spectroscopy and fluorescence-transfer measurements, Biopoly-mers, 24, 9, 1663-81


G :

P.A. Garris, Q.D. Walker and R.M. Wightman, 1996, Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals, Brain Research, 753, 225-234

O.B. Goodman, Jr., J.G. Krupnick, V.V. Gurevich, J.L. Benovic and J.H. Keen, 1997, Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain, J Biol Chem, 272, 23, 15017-22

O.B. Goodman, Jr., J.G. Krupnick, F. Santini, V.V. Gurevich, R.B. Penn, A.W. Gagnon, J.H. Keen and J.L. Benovic, 1996, Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2- adrenergic receptor, Nature, 383, 6599, 447-50

E. Grady, S. Bohm, K. McConalogue, A. Garland, J. Ansel, J. Olerud and N. Bunnett, 1997, Mechanisms attenuating cellular responses to neuropeptides: extracellular degradation of ligands and desensi-tization of receptors, J Investig Dermatol Symp Proc, 2, 1, 69-75

D.L. Greene, V.S. Hau, T.J. Abbruscato, H. Bartosz, A. Misicka, A.W. Lipkowski, S. Hom, T.J. Gillespie, V.J. Hruby and T.P. Davis, 1996, Enkephalin analog prodrugs: assessment of in vitro conversion, enzyme cleavage characterization and blood-brain barrier permeability, J Pharmacol Exp Ther, 277, 3, 1366-75


H :

M.M. Hosey, 1992, Diversity of structure, signaling and regulation within the family of muscarinic cholinergic receptors, Faseb J, 6, 3, 845-52


J :

I. Jerabek, J.P. Boulenger, J. Bradwejn, A. Drum-heller, Y.J. Lavallee and F.B. Jolicoeur, 1999a, CCK4-induced panic in healthy subjects II: neuroche-mical correlates, Eur Neuropsychophar-macol, 9, 1-2, 157-64

I. Jerabek, J.P. Boulenger, J. Bradwejn, Y.J. Lavallee and F.B. Jolicoeur, 1999b, CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects, Eur Neuropsychopharmacol, 9, 1-2, 149-55


K :

A.J. Kastin, T.W. Redding, R. Hall, G.M. Besser and A.V. Schally, 1975, Lipid mobilizing hormones of the hypothalamus and pituitary, Pharmacol Biochem Behav, 3, 1, 121-6

D.E. Keith, B. Anton, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, G. Monteillet-Agius, P.L. Stewart, C.J. Evans and M. von Zastrow, 1998, mu-opioid receptor internalization ; opiate drugs have differential effects on a conserved endocytotic mechanism in vitro and ihe mammalian brain, Mol Pharmacolt, 53, 3, 377-384

J. Kim, K. Kim and J.H. Ok, 1994, Application of carboxypeptidase Y and fast atom bombardment mass spectrometry for C-terminal sequencing of small peptides, Biochem Mol Biol Int, 33, 1, 55-64

P. Kitabgi, F. De Nadai, C. Rovere and J.N. Bidard, 1992, Biosynthesis, maturation, release, and degradation of neurotensin and neuromedin N, Ann N Y Acad Sci, 668, 30-42

C.S. Konkoy and T.P. Davis, 1995, Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases, J Neurochem, 65, 6, 2773-82

J.G. Krupnick, O.B. Goodman, Jr., J.H. Keen and J.L. Benovic, 1997, Arrestin/clathrin interaction. Localization of the clathrin binding domain of nonvisual arrestins to the carboxy terminus, J Biol Chem, 272, 23, 15011-6


L :

P.M. Laduron, 1984, Axonal transport of receptors: coexistence with neurotransmitter and recycling, Biochem Pharmacol, 33, 6, 897-903

P.M. Laduron, 1987a, Axonal transport of neuroreceptors: possible involvement in long-term memory, Neuroscience, 22, 3, 767-79

P.M. Laduron, 1987b, Axonal transport of receptors: characterization, role in receptor regulation and possible involvement in learning, J Recept Res, 7, 1-4, 417-34

P.M. Laduron, 1995, Functional consequences of retrograde axonal transport of receptor- bound neurotensin, Trends Pharmacol Sci, 16, 10, 338-43

R.J. Lefkowitz, S. Cotechia, P. Samana and T. Costa, 1993, Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins, Trends Pharmacol. Sci., 12, 183-188

R. Leurs, M.J. Smit, A.E. Alewijnse and H. Timmermann, 1998, Agonist-independent regulation of constitutively active G-protein-coupled receptors, TIBS, 23, 418-422

C.W. Lin, K. Shiosaki, T.R. Miller, D.G. Witte, B.R. Bianchi, C.A. Wolfram, H. Kopecka, R. Craig, F. Wagenaar and A.M. Nadzan, 1991, Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors, Mol Pharmacol, 39, 3, 346-51

A. Linden, M. Carlquist, S. Hansen and K. Uvnas-Moberg, 1989, Plasma concentrations of cholecys-tokinin, CCK-8, and CCK-33, 39 in rats, determined by a method based on enzyme digestion of gastrin before HPLC and RIA detection of CCK, Gut, 30, 2, 213-22

D.A. Lippman, N.M. Lee and H.H. Loh, 1992, Opioid-binding cell adhesion molecule (OBCAM)-related clones from a rat brain cDNA library, Gene, 117, 2, 249-54

C. Llorens-Cortes, 1998, [Identification of metabolic pathways of brain angiotensin II and angiotensin III: predominant role of angiotensin III in the control of vasopressin secretion], C R Seances Soc Biol Fil, 192, 4, 607-18

H.H. Loh and A.P. Smith, 1996, Regulation of acute and chronic opioid receptor functions by OBCAM, a cell adhesion-like molecule, NIDA Res Monogr, 161, 141-53

W.H. Luyten, 1986, A model for the acetylcholine binding site of the nicotinic acetylcholine receptor, J Neurosci Res, 16, 1, 51-73


M :

M. Maccarrone, M. Bari, T. Lorenzon, T. Bisogno, V. Di Marzo and A. Finazzi-Agro, 2000, Anandamide uptake by human endothelial cells and its regulation by nitric oxide, J Biol Chem, 275, 18, 13484-92

R. Mentlein and P. Dahms, 1994, Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes, J Neurochem, 62, 1, 27-36

R. Mentlein and T. Roos, 1996, Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells, Peptides, 17, 4, 709-20

G. Milligan and M.A. Grassie, 1997, How do G-proteins stay at the plasma membrane?, Essays Biochem, 32, 49-60

C.J. Molineaux, A. Lasdun, C. Michaud and M. Orlowski, 1988, Endopeptidase-24.15 is the primary enzyme that degrades luteinizing hormone releasing hormone both in vitro and in vivo, J Neurochem, 51, 2, 624-33

J.L. Montiel, F. Cornille, B.P. Roques and F. Noble, 1997, Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15, J Neurochem, 68, 1, 354-61


O :

M.C. Olianas, A. Adem, E. Karlsson and P. Onali, 1998, Identification of rat brain muscarinic M4 receptors coupled to cyclic AMP using the selective antagonist muscarinic toxin 3, Eur J Pharmacol, 357, 2-3, 235-42

R.W. Oppenheim, 1996, The concept of uptake and retrograde transport of neurotrophic molecules during development: history and present status, Neurochem Res, 21, 7, 769-77

M.C. Overton and K.J. Blumer, 2000, G-protein-coupled receptors function as oligomers in vivo, Curr Biol, 10, 6, 341-4


P :

C. Pantaloni, P. Brabet, B. Bilanges, A. Dumuis, S. Houssami, D. Spengler, J. Bockaert and L. Journot, 1996, Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation, J Biol Chem, 271, 36, 22146-51

W.M. Pardridge, J. Eisenberg and T. Yamada, 1985, Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels, J Neurochem, 44, 4, 1178-84

J.M. Patel, J.R. Martens, Y.D. Li, C.H. Gelband, M.K. Raizada and E.R. Block, 1998, Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation, Am J Physiol, 275, 6 Pt 1, L1061-8

E. Perry, M. Walker, J. Grace and R. Perry, 1999, Acetylcholine in mind: a neurotransmitter correlate of consciousness? [see comments], Trends Neurosci, 22, 6, 273-80

D. Piomelli, M. Beltramo, S. Glasnapp, S.Y. Lin, A. Goutopoulos, X.Q. Xie and A. Makriyannis, 1999, Structural determinants for recognition and translocation by the anandamide transporter, Proc Natl Acad Sci U S A, 96, 10, 5802-7

B. Poulain, 1998, Libération des neurotransmetteurs, in Physiologie des Neurones, Doin éditeur, Paris, D. Tritsh, D. Chesnoy-Marchais and A. Feltz, pp 529-78


R :

J.R. Reeve, Jr., V. Eysselein, G.A. Eberlein, P. Chew, F.J. Ho, V.D. Huebner, J.E. Shively, T.D. Lee and R.A. Liddle, 1991, Characterization of canine intestinal chole-cystokinin-58 lacking its carboxyl-terminal nonapeptide. Evidence for similar post-translational processing in brain and gut, J Biol Chem, 266, 21, 13770-6

I. Ridet and A. Privat, 2000, Volume transmission [letter; comment], Trends Neurosci, 23, 2, 58-9

J.L. Ridet, H. Tamir and A. Privat, 1994, Direct immunocytochemical localization of 5-hydroxy-tryptamine receptors in the adult rat spinal cord: a light and electron microscopic study using an anti-idiotypic antiserum, J Neurosci Res, 38, 1, 109-21

P.R. Robinson, G.B. Cohen, E.A. Zhukovsky and D.D. Oprian, 1992, Constitutively active mutants of rhodopsin, Neuron, 9, 719-725


S :

A. Salahpour, S. Angers and M. Bouvier, 2000, Functional Significance of oligomerisation of G-protein-coupled receptors, TEM, 11, 5, 163-168

S.L. Sandow, K. Heydon, M.W. Weible, 2nd, A.J. Reynolds, S.E. Bartlett and I.A. Hendry, 2000, Signalling organelle for retrograde axonal transport of internalized neurotrophins from the nerve terminal, Immunol Cell Biol, 78, 4, 430-5

H. Sankaran, A.C. Bailey and J.A. Willaims, 1981, CCK4 contains the full hormonal information of cholecystokinin in isolated pancreatic acini, Biochem Biophys Res Commun, 103, 4, 1356-62

P. Sarret, 2000, Signalisation par les récepteurs membranaires couplés aux protéines-G. Etude fonctionnelle des récepteurs de la somatostatine et de la neurotensine, Thesis, Nice-Sophia Antipolis, p 105

P.R. Schofield, K.C. McFarland, J.S. Hayflick, J.N. Wilcox, T.M. Cho, S. Roy, N.M. Lee, H.H. Loh and P.H. Seeburg, 1989, Molecular characterization of a new immunoglobulin superfamily protein with potential roles in opioid binding and cell contact, Embo J, 8, 2, 489-95

D. Spengler, C. Waeber, C. Pantaloni, F. Holsboer, J. Bockaert, P.H. Seeburg and L. Journot, 1993, Differential signal transduction by five splice variants of the PACAP receptor, Nature, 365, 6442, 170-5


T :

P. Tsao and M. von Zastrow, 2000, Down regulation of G protein-coupled receptors, Current Opinion in Neurobiology, 10, 365-369


V :

H.J. van Megen, H.G. Westenberg, J.A. Den Boer and R.S. Kahn, 1996, The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder, Eur Neuropsychopharmacol, 6, 3, 187-94

H. Vaudry and S. Jegou, 1995, Proopiomelanocortine, INSERM, Neuropeptides et neuromédiateurs, Epelbaum, J., 251-260

M. Vrecl, L. Anderson, A. Hanyaloglu, A.M. McGregor, A.D. Groarke, G. Milligan, P.L. Taylor and K.A. Eidne, 1998, Agonist-induced endocytosis and recycling of the gonadotropin-releasing hormone receptor: effect of beta-arrestin on internalization kinetics, Mol Endocrinol, 12, 12, 1818-29


Y :

N. Yabaluri and F. Medzihradsky, 1997, Down-regulation of mu-opioid receptor by full but noi partial agonists is independent of G-protein coupling, Mol Pharmacoll, 52, 896-902


Z :

J. Zhang, Y. Tong, M. Tian, R.N. Dehaven, L. Cortesburgos, E. Mansson, F. Simonin, B. Kieffer and L. Yu , 1998 a, Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family, J Pharmacol Exp Ther, 286, 1, 136-41

J. Zhang, S.S. Ferguson, L.S. Barak, S.R. Bodduluri, S.A. Laporte, P.Y. Law and M.G. Caron, 1998 b, Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor respon-siveness, Proc Natl Acad Sci U S A, 95, 12, 7157-62

M. Zoli and L.F. Agnati, 1996, Wiring and volume transmission in the central nervous system: the concept of closed and open synapses, Prog Neurobiol, 49, 4, 363-80

M. Zoli, A. Jansson, E. Sykova, L.F. Agnati and K. Fuxe, 1999, Volume transmission in the CNS and its relevance for neuropsychopharmacology, Trends Pharmacol Sci, 20, 4, 142-50